Fox Chase Researcher Identifies Potential New Treatment Target for GI Tumors
December 29, 2020
December 29, 2020
PHILADELPHIA, Pennsylvania, Dec. 29 (TNSRes) -- The Fox Chase Cancer Center issued the following news release:
Researchers at Fox Chase Cancer Center have identified a potential new target, a tyrosine kinase known as Wee1, for the treatment of gastrointestinal stromal tumor (GIST).
"Historically, all GIST were thought to be the same," said Lori Rink, PhD, assistant professor in the Molecular Therapeutics program at Fox Chase. "Now, we know that there are . . .
Researchers at Fox Chase Cancer Center have identified a potential new target, a tyrosine kinase known as Wee1, for the treatment of gastrointestinal stromal tumor (GIST).
"Historically, all GIST were thought to be the same," said Lori Rink, PhD, assistant professor in the Molecular Therapeutics program at Fox Chase. "Now, we know that there are . . .